BackBiodesix Overview

Biodesix Cost of Revenue

Cost of Revenue analysis for BDSX.

Quarterly Cost of Revenue

$4.21M
13.56% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$12.34M
3.52% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)